[go: up one dir, main page]

LT3472163T - Chelatiniai junginiai - Google Patents

Chelatiniai junginiai

Info

Publication number
LT3472163T
LT3472163T LTEP17731559.5T LT17731559T LT3472163T LT 3472163 T LT3472163 T LT 3472163T LT 17731559 T LT17731559 T LT 17731559T LT 3472163 T LT3472163 T LT 3472163T
Authority
LT
Lithuania
Prior art keywords
chelate compounds
chelate
compounds
Prior art date
Application number
LTEP17731559.5T
Other languages
English (en)
Inventor
Andreas Meijer
Mikkel Thaning
Brian Bales
Michael Rishel
Original Assignee
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare As filed Critical Ge Healthcare As
Publication of LT3472163T publication Critical patent/LT3472163T/lt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005Compounds without a metal-carbon linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LTEP17731559.5T 2016-06-20 2017-06-20 Chelatiniai junginiai LT3472163T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1610738.5A GB201610738D0 (en) 2016-06-20 2016-06-20 Chelate compounds
PCT/EP2017/065135 WO2017220610A1 (en) 2016-06-20 2017-06-20 Chelate compounds

Publications (1)

Publication Number Publication Date
LT3472163T true LT3472163T (lt) 2021-05-25

Family

ID=56895099

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP17731559.5T LT3472163T (lt) 2016-06-20 2017-06-20 Chelatiniai junginiai

Country Status (18)

Country Link
US (2) US11884686B2 (lt)
EP (1) EP3472163B1 (lt)
JP (2) JP7048591B2 (lt)
KR (2) KR20220123138A (lt)
CN (2) CN111499633B (lt)
AU (1) AU2017281189B2 (lt)
CA (1) CA3028027A1 (lt)
DK (1) DK3472163T3 (lt)
ES (1) ES2848580T3 (lt)
GB (1) GB201610738D0 (lt)
HU (1) HUE053402T2 (lt)
LT (1) LT3472163T (lt)
MX (1) MX2018016082A (lt)
PL (1) PL3472163T3 (lt)
RU (1) RU2747310C2 (lt)
SG (1) SG11201811380RA (lt)
WO (1) WO2017220610A1 (lt)
ZA (1) ZA201900371B (lt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201610738D0 (en) 2016-06-20 2016-08-03 Ge Healthcare As Chelate compounds
BR112019012757A2 (pt) * 2016-12-21 2019-11-26 Ge Healthcare As composto, composição farmacêutica, e, método.
CN111712477B (zh) 2017-12-20 2024-02-02 通用电气公司 阴离子螯合物化合物
PL4025259T3 (pl) * 2019-09-03 2025-03-03 Ge Healthcare As Izomery chelatu manganu
AU2022273867A1 (en) * 2021-05-13 2023-11-23 The General Hospital Corporation Molecular probes for in vivo detection of aldehydes
CN113801071B (zh) * 2021-09-14 2023-04-07 安徽普利药业有限公司 一种钆特酸葡甲胺的精制方法
CN115850343B (zh) * 2022-11-22 2025-10-21 南华大学 一种三草酸根合锰(ⅲ)酸铵的合成方法
EP4464708A1 (en) * 2023-05-17 2024-11-20 Bayer Aktiengesellschaft New contrast agents for use in diagnostic imaging

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU608759B2 (en) 1986-08-04 1991-04-18 Amersham Health Salutar Inc NMR imaging with paramagnetic polyvalents metal salts of poly-(acid-alkylene-amido)-alkanes
DE3640708C2 (de) 1986-11-28 1995-05-18 Schering Ag Verbesserte metallhaltige Pharmazeutika
US5334371A (en) 1988-07-20 1994-08-02 Schering Aktiengesellschaft Marcocyclic polyaza bicyclo compounds containing 5 or 6 membered rings, and method for MRI
DE3825040A1 (de) 1988-07-20 1990-01-25 Schering Ag, 13353 Berlin 5- oder 6-ring- enthaltende makrocyclische polyaza-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
WO1990003804A1 (en) 1988-09-27 1990-04-19 Salutar, Inc. Chelate compositions
FR2644785B1 (fr) 1989-03-24 1991-07-05 Guerbet Sa Nouveaux ligands macrocycliques azotes, procede de preparation, complexes metalliques formes par ces ligands et composition de diagnostic les contenant
GB9001245D0 (en) 1990-01-19 1990-03-21 Salutar Inc Compounds
US5215680A (en) 1990-07-10 1993-06-01 Cavitation-Control Technology, Inc. Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and therapeutic uses of microbubbles
US5428139A (en) 1991-12-10 1995-06-27 The Dow Chemical Company Bicyclopolyazamacrocyclophosphonic acid complexes for use as radiopharmaceuticals
DE69230970T2 (de) 1991-12-10 2001-01-04 The Dow Chemical Co., Midland Bicylclische, polyazamakrocyclocarbonsäure-komplexe, konjugate, herstellung und verwendung als kontraststoffe
SG46598A1 (en) 1991-12-10 1998-02-20 Dow Chemical Co Bicycloazamacroyclophosphonic acid conjugates contrast agents and preparation
NZ252554A (en) 1993-05-06 1998-01-26 Dow Chemical Co Bicyclopolyazamacrocyclophosphonic acid compounds, complexes, conjugates, as contrast imaging agents
FI933506A7 (fi) 1993-05-06 1994-11-07 Dow Global Technologies Inc Bisyklopolyatsamakrosyklokarboksyylihappokomplekseja, niiden konjugaat teja, menetelmä niiden valmistamiseksi ja käyttö varjoaineina
FR2794744B1 (fr) * 1999-06-09 2001-09-21 Guerbet Sa Complexes metalliques de polyaminoacides bicycliques, leur procede de preparation et leur application en imagerie medicale
FR2836916B1 (fr) 2002-03-05 2004-06-11 Guerbet Sa Oligomeres de chelates de gadolinium, leur application comme produits de contraste en imagerie par resonance magnetique et leurs intermediaires de synthese
FR2856689A1 (fr) * 2003-06-25 2004-12-31 Guerbet Sa Composes specifiques a forte relaxivite
WO2004112840A2 (en) 2003-06-25 2004-12-29 Guerbet Peptide conjugate for magnetic resonance imaging
CN101090739B (zh) 2004-07-02 2012-10-10 伯拉考成像股份公司 磁共振成像中用作高弛豫造影剂配体的1,4-二(羧甲基)氨基-6-甲基-全氢-1,4-二氮杂*(aazta)衍生物
EP1848466A4 (en) * 2005-01-31 2012-11-21 Yeda Res & Dev MRI CONTRAST AGENTS FOR DIAGNOSIS AND PROGNOSIS OF TUMORS
FR2891830B1 (fr) * 2005-10-07 2011-06-24 Guerbet Sa Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale
GB0609610D0 (en) 2006-05-15 2006-06-21 Stiftelsen Universitetsforskni MR perfusion
US8192721B2 (en) 2007-12-13 2012-06-05 Verrow Pharmaceuticals, Inc. Compositions useful for reducing toxicity associated with gadolinium-based contrast agents
US20090208421A1 (en) 2008-02-19 2009-08-20 Dominique Meyer Process for preparing a pharmaceutical formulation of contrast agents
NO331773B1 (no) * 2009-12-18 2012-03-26 Ge Healthcare As Mangankelater, sammensetninger omfattende slike og anvendelse av disse som kontrastmidler for magnettomografi (MR)
DK2721045T3 (en) * 2011-06-20 2017-07-24 Radiomedix Inc COMPOSITIONS, METHODS OF SYNTHESIS AND USE OF CARBOHYDRATE TARGETED AGENTS
CA2909919C (fr) 2013-04-26 2022-07-12 Guerbet Formulation de produit de contraste et son procede de preparation associe
US20160045623A1 (en) 2015-04-03 2016-02-18 Lipella Pharmaceuticals, Inc. Systems and Methods to Image Intercellular and Intercompartmental Defects with Magnetic Resonance Imaging (MRI)
WO2017089849A1 (en) 2015-11-26 2017-06-01 Debreceni Egyetem New 6-oxa-3,9, 15-triaza-bicyclo[9.3.1 ]pentadec a- 1 ( 14), 1 1 ( 15), 12-triene derivatives based compounds and their application as ligands of essential metal ion based mri and 52mn based pet contrast agents
CN108289970B (zh) 2015-11-30 2022-04-08 通用电气医疗集团股份有限公司 包含mri造影剂的组合的制剂
KR102703312B1 (ko) 2015-12-10 2024-09-05 브라코 이미징 에스.피.에이. 조영제
GB201610738D0 (en) 2016-06-20 2016-08-03 Ge Healthcare As Chelate compounds
BR112019012757A2 (pt) 2016-12-21 2019-11-26 Ge Healthcare As composto, composição farmacêutica, e, método.
CN111712477B (zh) 2017-12-20 2024-02-02 通用电气公司 阴离子螯合物化合物
PL4025259T3 (pl) 2019-09-03 2025-03-03 Ge Healthcare As Izomery chelatu manganu

Also Published As

Publication number Publication date
ES2848580T3 (es) 2021-08-10
CA3028027A1 (en) 2017-12-28
JP7594560B2 (ja) 2024-12-04
JP2019518082A (ja) 2019-06-27
US20240368205A1 (en) 2024-11-07
CN111499633B (zh) 2023-02-17
RU2018145061A3 (lt) 2020-07-28
AU2017281189A1 (en) 2019-01-17
DK3472163T3 (da) 2021-02-01
KR20220123138A (ko) 2022-09-05
EP3472163A1 (en) 2019-04-24
RU2747310C2 (ru) 2021-05-04
CN111499633A (zh) 2020-08-07
JP2022101556A (ja) 2022-07-06
KR20190018710A (ko) 2019-02-25
PL3472163T3 (pl) 2021-05-31
AU2017281189B2 (en) 2021-05-13
CN109641900A (zh) 2019-04-16
WO2017220610A1 (en) 2017-12-28
RU2018145061A (ru) 2020-07-21
BR112018076389A2 (pt) 2019-03-26
JP7048591B2 (ja) 2022-04-05
SG11201811380RA (en) 2019-01-30
CN109641900B (zh) 2021-08-24
NZ749394A (en) 2025-03-28
EP3472163B1 (en) 2020-11-11
HUE053402T2 (hu) 2021-06-28
MX2018016082A (es) 2019-09-10
KR102435941B1 (ko) 2022-08-25
GB201610738D0 (en) 2016-08-03
US20190233450A1 (en) 2019-08-01
ZA201900371B (en) 2019-10-30
US11884686B2 (en) 2024-01-30

Similar Documents

Publication Publication Date Title
GB201604647D0 (en) Novel compounds
GB201604638D0 (en) Novel compounds
GB201602854D0 (en) Novel compounds
GB201603779D0 (en) Novel compounds
GB201602934D0 (en) Compounds
GB201620119D0 (en) Compounds
ZA201900371B (en) Chelate compounds
GB201619694D0 (en) Compounds
GB201604027D0 (en) Compounds
GB201604020D0 (en) Compounds
SI3464336T1 (sl) Spojine
GB201610854D0 (en) Compounds
IL263228A (en) Benzoxaborole compounds
GB201608777D0 (en) Compounds
GB201613946D0 (en) Compounds
GB201604022D0 (en) Compounds
GB201604030D0 (en) Compounds
GB201713217D0 (en) Compounds
GB201621520D0 (en) Compounds
GB201622362D0 (en) Compounds
GB201604029D0 (en) Compounds
GB201601301D0 (en) Novel compounds
GB201622365D0 (en) Compounds
GB201604031D0 (en) Compounds
GB201720511D0 (en) Compounds